Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 1998; 5(4): 211-216


Protective role of carnitine against degenerative effect of ranitidine in liver and kidney tissues

 

Dr. Leyla CANPOLAT*

.




Abstract


 

Ranitidine are widely prescribed H2 receptor antagonists used in treatment of acid-peptic disorder ranitidine shows hepatotoxic effect in the liver and the kidney. Therefore, carnitine administration can be considered when the degeneration is limited to the liver and the kidney. In this study ranitidine- induced liver and kidney damages were investigated in adult Wistar rats. We utilized five groups as the control; ranitidine (10 mg/mg i.m.) for two months; ranitidine (10 mg/mg i.m.)+ carnitine (20mg/kg) mixed with water for one month; ranitidine+carnitine at the same doses for two months, and normal diet following ranitidine treated for two months, each group having 6 animals. In the hepatotoxity induced by ranitidine, there were Kupffer cell proliferation, fatty infiltration, mononuclear cell infiltration. In the cortex and medulla of the kidney there were inflammatory interstitial bleeding areas. In the groups treated with carnitine, the prognosis of the liver and the kidney could not be significantly changed. However, degeneration had been significantly decreased in both of the groups treated with carnitine. The tissues in the group having normal diet following ranitidine administration have shown similar changes to the groups with carnitine administration.

Key words: Ranitidine, carnitine, kidney, liver, structure, microscopy






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.